
FutureChem Co., Ltd. — Investor Relations & Filings
FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2026.03) | 2026-05-14 | Korean | |
| 투자판단관련주요경영사항 (프로스타뷰주사액([18F]플로라스타민) 식품의약품안전처 신약 허가) | 2026-05-04 | Korean | |
| 정기주주총회결과 | 2026-03-26 | Korean | |
| 기타경영사항(자율공시) (자기사채(제3회 전환사채) 소각 결정) | 2026-03-18 | Korean | |
| 사업보고서 (2025.12) | 2026-03-18 | Korean | |
| [기재정정]의결권대리행사권유참고서류 | 2026-03-13 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 45775286 | 분기보고서 (2026.03) | 2026-05-14 | Korean | ||
| 40650436 | 투자판단관련주요경영사항 (프로스타뷰주사액([18F]플로라스타민) 식품의약품안전처 신약 허가) | 2026-05-04 | Korean | ||
| 33044788 | 정기주주총회결과 | 2026-03-26 | Korean | ||
| 32972003 | 기타경영사항(자율공시) (자기사채(제3회 전환사채) 소각 결정) | 2026-03-18 | Korean | ||
| 32969804 | 사업보고서 (2025.12) | 2026-03-18 | Korean | ||
| 32939648 | [기재정정]의결권대리행사권유참고서류 | 2026-03-13 | Korean | ||
| 32939632 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-03-13 | Korean | ||
| 32932520 | [기재정정]의결권대리행사권유참고서류 | 2026-03-12 | Korean | ||
| 32915020 | 의결권대리행사권유참고서류 | 2026-03-09 | Korean | ||
| 32914811 | 주주총회소집공고 | 2026-03-09 | Korean | ||
| 32909435 | 감사보고서제출 | 2026-03-06 | Korean | ||
| 32868640 | 주주총회소집결의 | 2026-03-03 | Korean | ||
| 32830800 | 본점소재지변경 | 2026-02-24 | Korean | ||
|
2025
2 filings
| |||||
| 12202394 | 주요사항보고서(자기전환사채만기전취득결정) | 2025-12-22 | Korean | ||
| 7863254 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-09-19 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
FutureChem Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15895/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15895 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15895 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15895 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15895}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FutureChem Co., Ltd. (id: 15895)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.